BIONUMERIK Trademark

Trademark Overview

On Tuesday, May 18, 2004, a trademark application was filed for BIONUMERIK with the United States Patent and Trademark Office. The USPTO has given the BIONUMERIK trademark a serial number of 78420551. The federal status of this trademark filing is REGISTERED AND RENEWED as of Saturday, November 14, 2015. This trademark is owned by BioNumerik Pharmaceuticals, Inc.. The BIONUMERIK trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Designing novel medicines using mechanism-based drug discovery process
bionumerik

General Information

Serial Number78420551
Word MarkBIONUMERIK
Filing DateTuesday, May 18, 2004
Status800 - REGISTERED AND RENEWED
Status DateSaturday, November 14, 2015
Registration Number3004042
Registration DateTuesday, October 4, 2005
Mark Drawing3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, July 12, 2005

Trademark Statements

Pseudo MarkBIO NUMERIC
Goods and ServicesDesigning novel medicines using mechanism-based drug discovery process

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateTuesday, May 25, 2004
Primary Code042
First Use Anywhere DateMonday, November 30, 1998
First Use In Commerce DateTuesday, February 1, 2000

Trademark Owner History

Party NameBioNumerik Pharmaceuticals, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressSan Antonio, TX 78230
Party NameBioNumerik Pharmaceuticals, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSan Antonio, TX 78229
Party NameBioNumerik Pharmaceuticals, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSan Antonio, TX 78229

Trademark Events

Event DateEvent Description
Tuesday, May 25, 2004NEW APPLICATION ENTERED
Friday, December 17, 2004NON-FINAL ACTION WRITTEN
Friday, December 17, 2004NON-FINAL ACTION E-MAILED
Friday, January 14, 2005TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Friday, January 14, 2005ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, February 11, 2005PAPER RECEIVED
Friday, December 17, 2004ASSIGNED TO EXAMINER
Monday, March 7, 2005APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, March 11, 2005ASSIGNED TO LIE
Friday, April 1, 2005LAW OFFICE PUBLICATION REVIEW COMPLETED
Wednesday, June 22, 2005NOTICE OF PUBLICATION
Tuesday, October 4, 2005REGISTERED-PRINCIPAL REGISTER
Tuesday, January 11, 2011TEAS SECTION 8 RECEIVED
Friday, February 11, 2005CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, March 4, 2005AMENDMENT FROM APPLICANT ENTERED
Tuesday, July 12, 2005PUBLISHED FOR OPPOSITION
Thursday, January 27, 2011CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Thursday, January 27, 2011REGISTERED - SEC. 8 (6-YR) ACCEPTED
Wednesday, April 2, 2025TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, April 2, 2025TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, April 2, 2025TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Thursday, October 1, 2015TEAS SECTION 8 & 9 RECEIVED
Saturday, November 14, 2015CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Saturday, November 14, 2015REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
Saturday, November 14, 2015REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
Saturday, November 14, 2015NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
Friday, October 4, 2024COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
Wednesday, April 2, 2025APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Wednesday, June 25, 2025TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, June 25, 2025TEAS CHANGE OF OWNER ADDRESS RECEIVED
Wednesday, June 25, 2025APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Wednesday, April 2, 2025TEAS CHANGE OF OWNER ADDRESS RECEIVED
Wednesday, April 2, 2025ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

Related Keywords

bionumerik drug discovery process based mechanism novel medicines using designing